BioCentury

7:00 AM GMT, May 21, 2007
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Regulation

Limited use of ESAs

Limited use of ESAs

Limited use of ESAs
CMS has proposed limited coverage of ESAs for anemia in cancers where the presence of erythropoietin receptor on either

Read the full 270 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.